Table 1 The serum samples and the corresponding clinical parameters in the present study
Sample types and clinical data | Numbers n (%) |
|---|---|
Non-small Cell Lung Cancer | 111 (%) |
Age (year) | |
< 60 | 51 (45.9%) |
≥ 60 | 60 (54.1%) |
Gender | |
Male | 43 (38.7%) |
Female | 68 (61.3%) |
Tumor size (cm) | |
< 5 | 61 (55.0%) |
≥ 5 | 18 (16.2%) |
Unknown | 32 (28.8%) |
Histologic subtypes | |
Squamous cell carcinoma | 51 (45.9%) |
Adenocarcinoma | 60 (54.1%) |
TNM stage | |
I | 8 (7.2%) |
II | 36 (32.4%) |
III | 44 (39.7%) |
IV | 23 (20.7%) |
Distant metastasis | |
M0 | 88 (79.3%) |
M1 | 23 (20.7%) |
Lymph node metastasis | |
N0 | 38 (34.2%) |
N1-3 | 73 (65.8%) |
Pneumonia | 49 (100%) |
Age (year) | |
< 60 | 16 (32.7%) |
≥ 60 | 33 (67.3%) |
Gender | |
Male | 22 (44.9%) |
Female | 27 (55.1%) |
Healthy | 40 (100%) |
Age (year) | |
< 60 | 17 (42.5%) |
≥ 60 | 23 (57.5%) |
Gender | |
Male | 22 (55.0%) |
Female | 18 (45.0%) |